The Centers for Medicare & Medicaid Services late this afternoon released a final rule that makes programmatic and operational changes to the Medicare Advantage and prescription drug benefit programs for contract year 2019. Specifically, the rule revises program regulations to implement certain provisions of the Comprehensive Addiction and Recovery Act and the 21st Century Cures Act that direct Part D plan sponsors to establish a drug management program for beneficiaries at risk for prescription drug abuse or misuse. The final rule also updates regulations related to disclosure notices to allow for increased use of electronic posting of certain plan documents and finalizes a provision that directs plans to rely on a prescriber “preclusion list” rather than require that all prescribers be enrolled in Medicare, among other changes related to plan design and cost sharing.

Related News Articles

Headline
The Centers for Medicare & Medicaid Services April 6 finalized updates and changes to its Medicare Advantage and Part D payment methodologies for calendar…
Headline
The Centers for Medicare & Medicaid Services should develop prior authorization measures for the Medicare Advantage Star Ratings Program to minimize care…
Headline
The Centers for Medicare & Medicaid Services today proposed changes to the Medicare Advantage and Medicare Part D programs, including implementing various…
Headline
The Centers for Medicare & Medicaid Services yesterday announced proposed changes to the risk adjustment model for Medicare Advantage organizations and…
Headline
Medicare Advantage organizations received $6.7 billion in risk adjustment payments in 2017 for diagnoses that were not supported by the medical record,…
Headline
The Centers for Medicare & Medicaid Services today published its star ratings for 2020 Medicare Advantage and prescription drug plans. Most people…